| News

Grosspeter Tower – Basel’s sustainable model skyscraper

04.02.2019

With the ambitious goal of being a zero-emission building, Basel’s youngest skyscraper Grosspeter Tower was constructed to cover its own power requirements. Already during the construction phase, this impressive 78 meter office building by Burckhardt+Partner was awarded numerous prizes for its unique sustainable design and its building fabric. In particular, the façade, which is half windows, half integrated photovoltaic system - the first of its kind in Europe – make the building an efficient powerhouse.

Grosspeter Tower (img: Adriano Biondo)

After the official opening of Grosspeter Tower and move-in of Bayer in summer 2018, other well-known tenants have settled in the tower or will move into their newly developed offices in the coming months. Among others, Basel’s first Spaces Coworking solution operated by IWG will open its doors on the top floors from April 2019.

IWG – a leading provider of flexible workspaces – is strongly expanding in the Basel Region, aiming at establishing up to 10 new centers within the next three years. IWG has been a strong partner of BaselArea.swiss since opening its first center in Basel and has since hosted numerous foreign companies while starting up their business operations in the Basel region. To strengthen this partnership, BaselArea.swiss collaborates with IWG to offer its newly established Swiss entities of foreign companies and startups a soft start by providing free workspace for the first two months.

The building is ideally located in Basel’s business district, just a short walk from the railway station, shops and restaurants and has direct highway access. With the attached Ibis Styles, it offers on-site accommodation for business partners and customers.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

VectivBio secures investments totaling 110 million dollars
Basel Area Business & Innovation, Innovation, Invest

VectivBio secures investments totaling 110 million dollars

The Basel-based biotechnology firm VectivBio has received a capital injection of 110 million US dollars from both new and existing...

Read More
Polyphor receives up to 18 million dollars for development of antibiotics
Basel Area Business & Innovation, Innovation, Invest

Polyphor receives up to 18 million dollars for development of antibiotics

The Allschwil-based company Polyphor has received a second funding award from the global consortium CARB-X to combat antimicrobial resistance. Polyphor...

Read More
What makes Switzerland’s economy resilient in face of COVID pandemic
Basel Area Business & Innovation, Invest

What makes Switzerland’s economy resilient in face of COVID pandemic

The COVID-19 pandemic has hit economies worldwide – and we have not yet overcome it. However, Switzerland is among the...

Read More
DayOne Accelerator applications open
Basel Area Business & Innovation, Innovation

DayOne Accelerator applications open

We are excited to announce the opening of the call for the DayOne Accelerator, now in its 3rd year!

Read More
Matériaux Sabag printing concrete elements
Basel Area Business & Innovation, Innovation, Invest

Matériaux Sabag printing concrete elements

The Jura-based company Matériaux Sabag is now using a 3D printing solution to produce its concrete elements. This approach allows...

Read More
Six companies win the i4Challenge
Basel Area Business & Innovation, Innovation

Six companies win the i4Challenge

The i4Challenge expert jury has selected six winners from 18 finalists. The Industry 4.0 solutions range from 3D printing, IoT,...

Read More
Monte Rosa Therapeutics banks 96 million US dollars
Basel Area Business & Innovation, Innovation, Invest

Monte Rosa Therapeutics banks 96 million US dollars

The Basel-based biotechnology firm Monte Rosa Therapeutics has raised a total of 96 million US dollars after closing a successful...

Read More
Roche launches new coronavirus antibody test
Basel Area Business & Innovation, Innovation, Invest

Roche launches new coronavirus antibody test

Roche is launching on the market a new antibody test to determine coronavirus infections. This should help with the development...

Read More
Investors see great potential in Polyneuron
Basel Area Business & Innovation, Innovation, Invest

Investors see great potential in Polyneuron

The Basel-based company Polyneuron Pharmaceuticals extended its Series A funding round and has now raised a total of 36.5 million...

Read More
Lonza set to manufacture coronavirus drug for Humanigen
Basel Area Business & Innovation, Innovation, Invest

Lonza set to manufacture coronavirus drug for Humanigen

The Basel-based pharmaceutical supplier Lonza is supporting the US firm Humanigen in the development of a potential coronavirus therapeutic. Lonza...

Read More
1 2 3 21

Do you have a question? We'd like to hear from you.